EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating oxidative stress targeting treatments in in vitro models of placental stress relevant to preeclampsia

Dinara Afrose, Matt D Johansen, Valentina Nikolic, Natasa Karadzov Orlic, Zeljko Mikovic, Milan Stefanovic, Zoran Cakic, Philip M Hansbro, Lana McClements

Frontiers in Cell and Developmental Biology · 28.02.2025 · 13

DOI: 10.3389/fcell.2025.1539496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 28.02.2025. Verfasst von Dinara Afrose und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Foundation of Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preeclampsia is a complex pregnancy disorder characterized by the new onset of hypertension and organ dysfunction, often leading to significant maternal and fetal morbidity and mortality. Placental dysfunction is a hallmark feature of preeclampsia, which is often caused by inappropriate trophoblast cell function in association with oxidative stress, inflammation and/or pathological hypoxia. This study explores the role of oxidative stress in trophoblast cell-based models mimicking the preeclamptic placenta and evaluates potential therapeutic strategies targeting these mechanisms.

Methods

Uric acid (UA) and malondialdehyde (MDA) concentrations were measured in human plasma from women with preeclampsia (n = 24) or normotensive controls (n = 14) using colorimetric assays. Custom-made first trimester trophoblast cell line, ACH-3P, was exposed to various preeclampsia-like stimuli including hypoxia mimetic (dimethyloxalylglycine or DMOG, 1 mM), inflammation (tumour necrosis factor or TNF-α, 10 ng/mL) or mitochondria dysfunction agent, (Rhodamine-6G or Rho-6G, 1 μg/mL), ± aspirin (0.5 mM), metformin (0.5 mM), AD-01 (100 nM) or resveratrol (15 µM), for 48 h. Following treatments, UA/MDA, proliferation (MTT), wound scratch and cytometric bead, assays, were performed.

Results

Overall, MDA plasma concentration was increased in the preeclampsia group compared to healthy controls (p < 0.001) whereas UA showed a trend towards an increase (p = 0.06); when adjusted for differences in gestational age at blood sampling, MDA remained (p < 0.001) whereas UA became (p = 0.03) significantly correlated with preeclampsia. Our 2D first trimester trophoblast cell-based in vitro model of placental stress as observed in preeclampsia, mimicked the increase in UA concentration following treatment with DMOG (p < 0.0001), TNF-α (p < 0.05) or Rho-6G (p < 0.001) whereas MDA cell concentration increased only in the presence of DMOG (p < 0.0001) or Rho-6G (p < 0.001). Metformin was able to abrogate DMOG- (p < 0.01), Rho-6G- (p < 0.0001) or TNF-α- (p < 0.01) induced increase in UA, or DMOG- (p < 0.0001) or TNF-α- (p < 0.05)induced increase in MDA. AD-01 abrogated UA or MDA increase in the presence of TNF-α (p < 0.001) or Rho-6G (p < 0.001)/DMOG (p < 0.0001), respectively. The preeclampsia-like stimuli also mimicked adverse impact on trophoblast cell proliferation, migration and inflammation, most of which were restored with either aspirin, metformin, resveratrol, or AD-01 (p < 0.05).

Conclusion

Our 2D in vitro models recapitulate the response of the first trimester trophoblast cells to preeclampsia-like stresses, modelling inappropriate placental development, and demonstrate therapeutic potential of repurposed treatments.

Schlagwörter

Stichwörter der Autor:innen

aspirinmetforminoxidative stressplacentapreeclampsiapregnancyresveratroltrophoblast cells

Autor:innen und Institutionen

  • School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia.
  • Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia.
  • Department of Pharmacology with Toxicology, Faculty of Medicine, University of Nis, Nis, Serbia.
  • Department of Gynaecology and Obstetrics, Narodni Front, Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Department of Gynaecology and Obstetrics, Clinical Centre Nis, Nis, Serbia.

Förderung

  • National Heart Foundation of Australia

Zitieren

APA

Afrose, D., Johansen, M. D., Nikolic, V., Karadzov Orlic, N., Mikovic, Z., Stefanovic, M., Cakic, Z., Hansbro, P. M., & McClements, L. (2025). Evaluating oxidative stress targeting treatments in in vitro models of placental stress relevant to preeclampsia. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1539496

Vancouver

Afrose D, Johansen MD, Nikolic V, Karadzov Orlic N, Mikovic Z, Stefanovic M, et al. Evaluating oxidative stress targeting treatments in in vitro models of placental stress relevant to preeclampsia. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1539496

BibTeX
@article{Afrose2025,
  author = {Afrose, Dinara and Johansen, Matt D and Nikolic, Valentina and Karadzov Orlic, Natasa and Mikovic, Zeljko and Stefanovic, Milan and Cakic, Zoran and Hansbro, Philip M and McClements, Lana},
  title = {Evaluating oxidative stress targeting treatments in in vitro models of placental stress relevant to preeclampsia},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1539496}
}
Kostenlos starten →